ANVISA publica lista de medicamentos similares intercambiáveis

anvisa

A partir da criação da Anvisa e da implantação da política dos medicamentos genéricos, foram estabelecidos importantes regulamentos sanitários. Esses novos regulamentos alcançaram não somente os medicamentos genéricos, mas também os medicamentos similares. Tal fato decorreu da necessidade de regulação do mercado farmacêutico brasileiro para aprimorar os critérios de garantia da qualidade, eficácia e segurança dos medicamentos, tanto daqueles que já se encontravam no mercado quanto dos que viessem a ser registrados na Anvisa.

Dentre outras, a Anvisa publicou em 2003 a Resolução da Diretoria Colegiada – RDC no 134/2003, que estabeleceu critérios para a adequação dos medicamentos similares já registrados e comercializados no Brasil. A referida RDC obrigou os detentores de registro de medicamentos similares a apresentarem estudos comparativos com o medicamento de referência tais como, equivalência farmacêutica, perfil de dissolução e bioequivalência/biodisponibilidade relativa (BD/BE), se aplicável ao fármaco e forma farmacêutica.

O objetivo destas determinações é a comprovação da equivalência terapêutica entre o medicamento similar registrado e o seu respectivo medicamento de referência. Em 2014, por meio da RDC 58/2014, que definiu as medidas a serem adotadas junto à Anvisa pelos titulares de registro de medicamentos para a intercambialidade de medicamentos similares com o medicamento de referência, ficou determinada a disponibilização no site da Agência da relação dos medicamentos similares indicando os medicamentos de referência com os quais são intercambiáveis para fins de consulta pela população por profissionais de saúde ou qualquer outro interessado. A lista será atualizada mensalmente, à medida que novos similares forem registrados e renovados com a análise dos estudos comparativos citados.

Todos os medicamentos similares intercambiáveis  constantes da lista também terão na bula do medicamento a  informação a respeito da intercambialidade, conforme determina a RDC 58/2014. Tal informação será apresentada por meio da frase: MEDICAMENTO SIMILAR EQUIVALENTE AO MEDICAMENTO DE REFERÊNCIA. A referida informação deve ser incluída  na seção da bula “Identificação do Medicamento”, logo abaixo da Denominação Comum Brasileira  (DCB) do(s) princípio(s) ativo(s) do medicamento, respeitando o modelo já existente de bula descrito no Anexo I da RDC 47/09.

Para essa inclusão, a empresa detentora de registro de medicamento similar intercambiável terá o prazo de 1 (um) ano a contar de sua inclusão na lista publicada no site da Anvisa. O peticionamento deverá ser feito por meio do assunto “10756 – SIMILAR – Notificação de alteração de texto de bula para adequação à intercambialidade” e deverá ser seguido o fluxo de peticionamento de bulas, de acordo com as orientações do Guia de Submissão Eletrônica de Texto de Bula.

Para acessar a lista, clique aqui!!!

Fonte: Assessoria de Imprensa da Anvisa



25 Comentários

  • Havikng read this I elieved it wass really enlightening.
    I appreciate yoou taking the time and effort
    to putt this informative article together. I once again find myself spending way too much
    time both reading and posting comments. But so what, it was
    still worh it!

  • Hi friends, how is all, and what you want to say about this article, in my
    vidw its genuinely awesome in favor of me.

  • That iss really fascinating, You’re an excessively skilled blogger.

    I have joined your ferd and look forward to in search of extra of your wonderful post.
    Also, I have shared your website in my social networks

  • Does your blog have a contact page? I’m having problems locating it but,
    I’d like to send you an e-mail. I’ve got
    some ideas for your bllog you might be interesteed in hearing.
    Either way, greawt blog andd I look forward to seeinng it develop over
    time.

  • Hi all, hhere every person is sharing such know-how,
    therefore it’s nice to read this website, and I used
    to pay a visit this blog all the time.

  • I would like to thank you for the efforts you’ve put in writing this site.

    I really hope to check out the same high-grade content by you later
    on as well. In fact, your creative writing abilities
    has motivated me to get my very own blog now 😉

  • Hello friends, its enormous article regarding educationand completely explained, keep it up all thhe time.

  • Fine way of telling, and pleaant article to take information about my presentation focus, which i am going to
    convey in inhstitution of higher education.

  • Have you ever thought about publishing an e-book or guest authoring on other websites?
    I have a blog centered on the same ideas you discuss and would love to have
    you share some stories/information. I know my visitors would appreciate your
    work. If you are even remotely interested, feel free to shoot
    me an e mail.

  • Cann you tell uss moree about this? I’d like to find ouut some additional information.

  • I’d like to find out more? I’d care to find out moee details.

  • I was curious if yyou ever considered changing the structure of your site?
    Its very well written; I love what youve goot to say. Butt
    maybe you could a little more in the way of content so people could connect with it
    better. Youve got ann awful lot of text for only having one or
    two images. Maybe you could space iit out better?

  • Great blog you have got here.. It’s difficult to find high-quality writing like yours nowadays.

    I really appreciate individuals like you! Take care!!

  • Oh my goodness! Awesome articlpe dude! Thank you so much, However I am having troubles with your RSS.

    I don’t know the reason why I am unable to subscribe to it.
    Is there anhbody having similar RSS issues? Anyone who knows thee solution can you kindly respond?
    Thanks!!

  • Thank you for another great post. The plasce else maay ust
    anyone get that type of information in such an ideal method of writing?
    I have a presentation next week, and I’m oon the search for such information.

  • This site was… hhow do yoou say it? Relevant!! Finally I have found something that helped me.
    Thanks!

  • Hello to every body, it’s my first pay a visit of this webpage;
    this web site consits of awesome and inn fact excellent data for readers.

  • Asking questions arre actually ppleasant thing if you are
    noot understanding something entirely, but this paragraph provides pleasant understanding yet.

  • Fine way of describing, and pleasant post to obtain data concerning my presentation subject, which i am
    going to present in academy.

  • I waas suggested this website by way of my cousin. I’m now not certain whether or not this submit is written through him as no
    one else know such certasin about mmy trouble.
    You arre incredible! Thanks!

  • I know this iif off topic but I’m looking intoo starting my own weblog and wass
    wondering hat all is needed to gett setup? I’m assuming havging a
    blog like yours would cost a pretty penny?
    I’m not very internet savvyy so I’m not 100% positive. Any
    recommendations or advice would be greatly appreciated.
    Kudos

  • I think this is amomg the most significant information for me.

    And i am glazd studying your article. Buut should statement on few normjal issues, The web
    site style is perfect, the aryicles is in reality great :
    D. Good process, cheers

  • Hi there, i read yourr blog from tome tto time and i oown a similar
    one andd i was just wondering if you get a lot of spam comments?
    If so hoow do you stop it, any plugin or anything you can advise?
    I get so much lately it’s driving me crdazy so any support is very
    much appreciated.

  • Hello to every body, it’s my first pay a quick visit of this blog; this
    web site includes awesome and genuinelly fine information designed for visitors.

  • Wonderful beat ! I would liuke to apprentice even as you ammend your web site, how could i suscribe for a weblog
    website? The account aided me a apprdopriate deal.
    I have bwen a little bit acquainted of this your broadcast offered bright transparent
    idea

Deixe uma resposta